Camp4 Therapeutics News

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Monte Rosa Therapeutics (GLUE) and CAMP4 Therapeutics Corporation (CAMP)

TipRanksDec 6, 2024 07:47 ET

Piper Sandler Maintains Camp4 Therapeutics(CAMP.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsDec 6, 2024 07:31 ET

Piper Sandler Maintains Camp4 Therapeutics(CAMP.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 22, 2024 07:33 ET

Leerink Partners Initiates Camp4 Therapeutics(CAMP.US) With Buy Rating, Announces Target Price $17

Moomoo NewsNov 5, 2024 06:36 ET

William Blair Initiates Camp4 Therapeutics(CAMP.US) With Buy Rating

Moomoo NewsNov 5, 2024 06:36 ET

Camp4 Therapeutics Initiated With an Outperform at Leerink

TipRanksNov 5, 2024 06:22 ET

CalAmp Price Target Announced at $18.00/Share by Piper Sandler

Dow JonesNov 5, 2024 06:04 ET

CalAmp Initiated at Overweight by Piper Sandler

Dow JonesNov 5, 2024 06:04 ET

Camp4 Therapeutics Analyst Ratings

BenzingaNov 5, 2024 05:54 ET

Piper Sandler Initiates Camp4 Therapeutics(CAMP.US) With Buy Rating, Announces Target Price $18

Moomoo NewsNov 5, 2024 05:40 ET